Nancy DiFronzo

1.6k total citations
23 papers, 468 citations indexed

About

Nancy DiFronzo is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Nancy DiFronzo has authored 23 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nancy DiFronzo's work include Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Virus-based gene therapy research (3 papers). Nancy DiFronzo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Virus-based gene therapy research (3 papers). Nancy DiFronzo collaborates with scholars based in United States, Italy and Japan. Nancy DiFronzo's co-authors include Christie A. Holland, Mary M. Horowitz, John R. Wingard, Anamaris M. Colberg‐Poley, Vincent T. Ho, Brent R. Logan, Daniel J. Weisdorf, Tracey J. Nickola, Mary C. Rose and Yajun Chen and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Virology.

In The Last Decade

Nancy DiFronzo

21 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy DiFronzo United States	11	255	142	86	85	66	23	468
JJ Wielenga Netherlands	8	186 0.7×	143 1.0×	73 0.8×	80 0.9×	101 1.5×	9	492
Susan E. Burkett United States	8	132 0.5×	206 1.5×	179 2.1×	85 1.0×	117 1.8×	8	789
Manuel Jurado Spain	15	253 1.0×	153 1.1×	52 0.6×	131 1.5×	123 1.9×	37	670
S Tanikawa Japan	13	216 0.8×	58 0.4×	29 0.3×	147 1.7×	61 0.9×	35	534
Hilde Demuynck Belgium	11	217 0.9×	86 0.6×	64 0.7×	153 1.8×	121 1.8×	28	689
Nobuyuki Takayama Japan	15	242 0.9×	135 1.0×	37 0.4×	120 1.4×	229 3.5×	55	753
Douglas P. Blackall United States	14	240 0.9×	177 1.2×	22 0.3×	25 0.3×	140 2.1×	47	590
Claire Aguilar France	13	122 0.5×	246 1.7×	29 0.3×	73 0.9×	66 1.0×	31	631
Elizabeth A. Moulton United States	10	131 0.5×	399 2.8×	22 0.3×	32 0.4×	69 1.0×	19	558
Terence Flood United Kingdom	13	143 0.6×	375 2.6×	37 0.4×	39 0.5×	55 0.8×	19	532

Countries citing papers authored by Nancy DiFronzo

Since Specialization

Citations

This map shows the geographic impact of Nancy DiFronzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy DiFronzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy DiFronzo more than expected).

Fields of papers citing papers by Nancy DiFronzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy DiFronzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy DiFronzo. The network helps show where Nancy DiFronzo may publish in the future.

Co-authorship network of co-authors of Nancy DiFronzo

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy DiFronzo. A scholar is included among the top collaborators of Nancy DiFronzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy DiFronzo. Nancy DiFronzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeZern, Amy E., Michael Otterstatter, Nancy Gillis, et al.. (2024). Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS). Blood. 144(Supplement 1). 1831–1831.

DeZern, Amy E., Johannes B. Goll, Sridhar Nonavinkere Srivatsan, et al.. (2023). Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study. Blood. 142(Supplement 1). 1860–1860. 2 indexed citations

Vasu, Sumithira, Shernan G. Holtan, Akiko Shimamura, et al.. (2022). Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force. Transplantation and Cellular Therapy. 29(1). 5–9. 8 indexed citations

Padron, Eric, Steven D. Gore, Nancy Gillis, et al.. (2021). COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study. Blood. 138(Supplement 1). 2611–2611.

Tamburro, Robert F., Kenneth R. Cooke, Stella M. Davies, et al.. (2020). Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary. Annals of the American Thoracic Society. 18(3). 381–394. 26 indexed citations

Yanik, Gregory A., Mary M. Horowitz, Daniel J. Weisdorf, et al.. (2014). Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol. Biology of Blood and Marrow Transplantation. 20(6). 858–864. 49 indexed citations

Yanik, Gregory A., Vincent T. Ho, Mary M. Horowitz, et al.. (2013). Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study. Biology of Blood and Marrow Transplantation. 19(2). S169–S169. 2 indexed citations

Tolar, Jakub, H. Joachim Deeg, Sally Arai, et al.. (2012). Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels. Biology of Blood and Marrow Transplantation. 18(7). 1007–1011. 35 indexed citations

Horwitz, Edwin M., Mary M. Horowitz, Nancy DiFronzo, Donald B. Kohn, & Helen E. Heslop. (2010). Guidance for Developing Phase II Cell Therapy Trial Proposals for Consideration by the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation. 17(2). 192–196. 1 indexed citations

10.

Pulsipher, Michael A., Neal S. Young, Jakub Tolar, et al.. (2010). Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biologic, and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biology of Blood and Marrow Transplantation. 17(3). 291–299. 31 indexed citations

11.

Alousi, Amin M., Daniel J. Weisdorf, Brent R. Logan, et al.. (2009). Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 114(3). 511–517. 147 indexed citations

12.

Chen, Yajun, Tracey J. Nickola, Nancy DiFronzo, Anamaris M. Colberg‐Poley, & Mary C. Rose. (2005). Dexamethasone-Mediated Repression of MUC5AC Gene Expression in Human Lung Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 34(3). 338–347. 63 indexed citations

13.

DiFronzo, Nancy, et al.. (2003). Duplication of U3 Sequences in the Long Terminal Repeat of Mink Cell Focus-Inducing Viruses Generates Redundancies of Transcription Factor Binding Sites Important for the Induction of Thymomas. Journal of Virology. 77(5). 3326–3333. 1 indexed citations

14.

Su, Yan, et al.. (2003). Convergence of RNA cis Elements and Cellular Polyadenylation Factors in the Regulation of Human Cytomegalovirus UL37 Exon 1 Unspliced RNA Production. Journal of Virology. 77(23). 12729–12741. 14 indexed citations

15.

DiFronzo, Nancy & Christie A. Holland. (1999). Sequence-Specific and/or Stereospecific Constraints of the U3 Enhancer Elements of MCF 247-W Are Important for Pathogenicity. Journal of Virology. 73(1). 234–241. 6 indexed citations

16.

DiFronzo, Nancy, Cynthia A. Pise-Masison, Roberto Fernandez-Larsson, & Christie A. Holland. (1997). Viral determinants of HIV-1 sufficient to extend tropism to macrophages are distinct from the determinants that control the cytopathic phenotype in HL-60 cells. AIDS. 11(14). 1681–1688. 7 indexed citations

17.

Loiler, Scott, Nancy DiFronzo, & Christie A. Holland. (1997). Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line. Journal of Virology. 71(6). 4825–4828. 12 indexed citations

18.

DiFronzo, Nancy & Christie A. Holland. (1993). A direct demonstration of recombination between an injected virus and endogenous viral sequences, resulting in the generation of mink cell focus-inducing viruses in AKR mice. Journal of Virology. 67(7). 3763–3770. 22 indexed citations

19.

DiFronzo, Nancy & Louis W. Schierman. (1989). Transplantable Marek's disease lymphomas. III. Induction of MHC‐restricted tumor immunity by lymphoblastoid cells in F₁ hosts. International Journal of Cancer. 44(3). 474–476. 10 indexed citations

20.

Gilmour, D. G., et al.. (1986). Genetic interaction between Non-MHC T- and B-cell alloantigens in response to rous sarcomas in chickens. Immunogenetics. 23(1). 1–6. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact